Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
6.37
-0.40 (-5.91%)
At close: Sep 11, 2025, 3:59 PM
Cyclacel Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
PE Ratio | -66.85 | -22.66 | -84.96 | -441 |
PEG Ratio | 0.70 | -37.99 | 7.58 | -2.9 |
PS Ratio | 17.43K | 1.22K | n/a | n/a |
PB Ratio | -344.75 | 842.04 | 88.14 | 220.97 |
P/FCF Ratio | -93.8 | -31.71 | -86.44 | -448.6 |
P/OCF Ratio | -93.8 | -31.72 | -86.47 | -449.25 |
OCF/S Ratio | -185.81 | -38.36 | n/a | n/a |
Debt / Equity Ratio | n/a | 0.06 | 0.01 | 0.00 |
Quick Ratio | 0.59 | 0.91 | 3.25 | 7.46 |
Current Ratio | 0.59 | 0.91 | 3.25 | 7.56 |
Asset Turnover | 0.01 | 0.05 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity | 5.16 | -37.16 | -1.04 | -0.5 |
Return on Assets | -2.74 | -2.56 | -0.76 | -0.44 |
Return on Invested Capital | 5.16 | -34.89 | -1.1 | -0.51 |
Dividend Yield | n/a | 0.00 | 0.00 | 0.00 |
Payout Ratio | n/a | -0.01 | -0.01 | -0.01 |
Gross Profit Margin | 1.00 | 1.00 | n/a | n/a |
Net Profit Margin | -260.74 | -53.7 | n/a | n/a |
Pretax Profit Margin | -278.93 | -60.84 | n/a | n/a |
Operating Profit Margin | -279.16 | -60.6 | n/a | n/a |
FCF Margin | -185.81 | -38.38 | n/a | n/a |
EBITDA Margin | -279.02 | -60.53 | n/a | n/a |